We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SSNC:NASDAQSS&C Technologies Holdings, Inc. Analysis

Data as of 2026-03-11 - not real-time

$73.67

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

SS&C Technologies is trading at $73.67, marginally above its 20‑day SMA of $73.33 but still well below the 50‑day ($79.92) and 200‑day ($83.66) moving averages, indicating a short‑term pull‑back within a longer‑term downtrend. The RSI sits at 42, suggesting neutral momentum, while the MACD histogram is positive, giving a modest bullish signal despite the overall bearish trend. Volatility is elevated at 42% over the past 30 days and beta is sub‑1.0 (0.86), pointing to higher price swings but lower systematic risk. The DCF fair value of $72.24 is below the current price, yet the model projects a 34% upside to the median analyst target of $99, implying the market may be undervaluing the stock. Revenue grew 8% YoY to $6.27 B with a gross margin of 48%, and forward earnings per share of $7.22 translate to a forward P/E of 10 versus an industry average of 37, highlighting a significant valuation discount. The company delivered Q4 EPS of $1.69 beating consensus, raised guidance for Q1 and FY 2026, and completed a $579 M buyback, underscoring strong cash generation. With a dividend yield of 1.47% and a payout ratio of 33%, the dividend appears sustainable given robust operating cash flow of $1.74 B.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below 50‑day and 200‑day SMAs indicating bearish bias
  • Positive MACD histogram offering limited upside
  • Decreasing volume trend reducing short‑term liquidity

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E of 10 versus industry average of 37
  • Revenue growth of 8% with strong operating margins
  • Recent earnings beat and $579 M buyback signaling confidence

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Recurring SaaS revenue model and global client base
  • Sustainable dividend with 33% payout ratio
  • Significant upside potential to $99 target and continued cash flow generation

Key Metrics & Analysis

Financial Health

Revenue Growth8.10%
Profit Margin12.71%
P/E Ratio23.4
ROE11.79%
ROA4.52%
Debt/Equity110.84
P/B Ratio2.6
Op. Cash Flow$1.7B
Free Cash Flow$1.3B
Industry P/E36.8

Technical Analysis

TrendBearish
RSI42.4
Support$69.00
Resistance$77.24
MA 20$73.33
MA 50$79.92
MA 200$83.66
MACDBullish
VolumeDecreasing
Fear & Greed Index76.91

Valuation

Fair Value$72.24
Target Price$99.00
Upside/Downside34.38%
GradeUndervalued
TypeBlend
Dividend Yield1.47%

Risk Assessment

Beta0.86
Volatility42.35%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.